All CD8-predominant AITL cases tested positive for EBER with a median positive cell count of 7.5/HPF (range: 1–150/HPF), which is higher than in common AITL (median: 3.5/HPF, range: 0–20/HFP), although not statistically significant (P = 0.263). The gene discussed is CD8A; the disease is angioimmunoblastic T-cell lymphoma.